Drug Policy Archives - Page 2 of 57

Cannabusiness lawsuit highlights need for Congress to clarify federal treatment of marijuana

Commentary by Geoffrey Lawrence

What is 7-OH and why did the FDA seize this potentially life-saving substance?

Commentary by Geoffrey Lawrence

Ohio’s reckless kratom ban could create new public safety concerns and grow the illegal market

Commentary by Michelle Minton

Psychedelics Policy Newsletter: New real-world psilocybin study, ibogaine educational materials, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — December 2025

Commentary by Gregory Ferenstein

Massachusetts bills offer a pathway toward expanded psychedelic access

Testimony by Kaitlyn Boecker

New study details how legal psychedelic services can treat depression, anxiety

Commentary by Gregory Ferenstein

Proposed Model Policy: “Veterans Mental Health Innovations Act”

Backgrounder by Kaitlyn Boecker, Geoffrey Lawrence and Leonard Gilroy

Model legislation would authorize groundbreaking research into ibogaine for mental health

Backgrounder by Kaitlyn Boecker, Geoffrey Lawrence and Leonard Gilroy

More Drug Policy

Prev
1
2
3
4
5
6
7
...
57
Next